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Rapport de synthèse 
Active Smoking and the Risk of Type 2 Diabetes: A Systemafü:: Review and Meta-analysis 
Tabagisme actif et risque de diabète de type 2 : revue systématique et méta-analyse 
Introduction : plusieurs études observationnelles suggèrent qu'il existe une association entre le 
tabagisme actif et l'incidence du diabète de type 2. Toutefois de telles études n'ont jamais été 
synthétisées de façon systématique. 
Objectif: conduire une revue systématique avec meta-analyse des études évaluant l'association 
entre le tabagisme actif et l'incidence du diabète de type 2. 
Méthode : nous avons effectué une recherche dans les bases de donnée électroniques MEDLINE et 
EMBASE de 1966 à mai 2007, et l'avons complétée par une recherche manuelle des bibliographies des 
articles clés retenus ainsi que par la recherche d'abstracts de congrès scientifiques et le contact 
d'experts. Pour être inclues dans notre revue, les études devaient avoir un design de type cohorte, 
reporter un risque de glycémie à jeun élevée, d'intolérance au glucose ou de diabète de type 2 en 
relation avec le statut tabagique des participants lors du recrutement et devaient exclure les sujets 
avec un diabète au début de l'étude. Deux auteurs ont sélectionné de façon indépendante les études 
et ont extrait les données. Les risques relatifs de diabète étaient ensuite compilés, utilisant un modèle 
de type « random effect ». 
Résultats: la recherche a aboutit à 25 études de cohorte prospectives (N=1'165'374 participants) et 
a reporté en tout 45'844 cas de diabète de type 2 pendant une durée de suivi s'étendant sur 5 à 30 
années. Sur les 25 études, 24 reportaient un risque augmenté de diabète chez les fumeurs par 
comparaison aux non fumeurs. Le risque relatif (RR) commun de toutes les études était de 1.44 
(intervalle de confiance (IC) à 95% : 1.31-1.58). Le risque de diabète était plus élevé chez les 
fumeurs de plus de 20 cigarettes par jour (RR : 1.61, IC 95% : 1.43-1.80) en comparaison aux 
fumeurs ayant une consommation inférieure (RR : 1.29, IC 95% : 1.13-1.48) et le risque était 
moindre pour les anciens fumeurs (RR: 1.23; IC 95% : 1.14-1.33) comparé aux fumeurs actifs. Ces 
éléments parlent en faveur d'un effet dose-réponse et donc d'une relation de causalité, sans pour 
autant la prouver. 
Conclusion : notre étude révèle que le tabagisme actif est associé avec un risque augmenté de 44% 
de diabète de type 2. Des recherches futures sont nécessaires pour évaluer si cette association est 
causale et pour clarifier les mécanismes d'action. Dans l'intervalle, les professionnels de santé 
devraient mentionner l'éviction du diabète comme une raison supplémentaire d'arrêter de fumer ou de 
ne pas commencer à fumer. 
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MOKING IS THE LEADING CAUSE 
of avoidable death globally. 1 Ev-
ery year about 4 million people 
die because of smoking and it 
is estimated that tobacco causes about 
8.8% of deaths worldwide. 2 The mag-
nitude of this public health challenge 
is growing, and estimates suggest that 
as many as 10 million people may die 
from smoking-related causes in 2025. 3 
The prevalence of diabetes is also ex-
pected to have a major increase by the 
year 2025,'1 a concerning trend given 
that diabetes imposes a significant pub-
lic health burden and large demands on 
health care systems.5 
A number of primary studies have as-
sessed the association between smok-
ing and incidence of glucose abnor-
malities, suggesting that active smoking 
could be independently associated with 
glucose intolerance, impaired fasting 
glucose, and type 2 diabetes; smoking 
may ù1erefore be a modifiable risk factor 
for type 2 diabetes. Sorne of these stud-
ies have been summarized in qualita-
tive reviews.6-8 I-lowever, to our knowl-
See also p 2675 and Patient Page. 
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Context Observational studies have suggested an association between active smok-
ing and the incidence of type 2 diabetes. 
Objective To conduct a systematic review with meta-analysis of studies assessing 
the association between active smoking and incidence of type 2 diabetes. 
Data Sources A search of MEDLINE (1966 to May 2007) and EMBASE (1980 to 
May 2007) databases was supplemented by manual searches of bibliographies of key 
retrieved articles, reviews of abstracts from scientific meetings, and contact with ex-
perts. 
Study Selection Studies were included if they reported risk of impaired fasting 
glucose, impaired glucose tolerance, or type 2 diabetes in relationship to smoking 
status at baseline; had a cohort design; and excluded persons with diabetes at base-
line. 
Data Extraction and Data Synthesis Two authors independently extracted the 
data, including the presence or absence of active smoking at baseline, the risk of dia-
betes, methods used to detect diabetes, and key criteria of study quality. Relative risks 
(RRs) were pooled using a random-effects mode!. Associations were tested in sub-
groups representing different patient characteristics and study quality criteria. 
Results The search yielded 25 prospective cohort studies (N = 1.2 million partici-
pants) that reported 45 844 incident cases of diabetes during a study follow-up pe-
riod ranging from 5 to 30 years. Of the 25 studies, 24 reported adjusted RRs greater 
than 1 (range for ail studies, 0.82-3.74). The pooled adjusted RR was 1.44 (95% con-
fidence interval [Cl], 1.31-1.58). Results were consistent and statistically significant in 
ail subgroups. The risk of diabetes was greater for heavy smokers (220 cigarettes/ 
day; RR, 1.61; 95% Cl, 1.43-1.80) than for lighter smokers (RR, 1.29; 95% Cl, 1.13-
1.48) and lower for former smokers (RR, 1.23; 95% Cl, 1.14-1.33) compared with 
active smokers, consistent with a dose-response phenomenon. 
Conclusion Active smoking is associated with an increased risk of type 2 diabetes. 
Future research should attempt to establish whether this association is causal and to 
clarify its mechanisms. 
JAMA. 2007;298(22):2654-2664 
edge, the quality of existing studies has 
not been systernatically asscssed and the 
clinical features of these studies have 
not been fully assessed to further char-
acterize this potential association and 
its determinants. 
We therefore conducted a system-
atic review and meta-analysis of pro-
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spective cohort studies describing the 
association between active smoking and 
the incidence of diabetes or other glu-
cose metabolism irregularities. 
METHODS 
Search Strategy 
We conductecl a systematic literature 
search of MEDLINE (1966 to May 
2007) and EMBASE (1980 to May 
2007) for studies describing the asso-
ciation between active smoking (in 
contrast to passive or secondhand 
smoking) and impaired fasting glu-
cose, impaired glucose tolerance, or 
type 2 diabetes. In addition, we 
searched the reference lists of ail iden-
tified relevant publications, reviewcd 
abstracts of selected scientific meet-
ings (the Society for Rescarch on 
Nicotine and Tobacco and the Ameri-
can Diabetes Association meetings) 
and contactecl experts in smoking ces-
sation and diabetes. 'vVe considcrccl 
articles publishecl in any language. We 
used a literature searching approach 
describecl by Egger et al9 for iclentify-
ing observational stuclies and stuclies 
of prognosis. 
Three search themes were com-
bined using the Boolean operator 
"and." The first theme, glucose 
metabo lism irregularity, corn binecl 
exploclecl versions of Meclical Subject 
Headings (MeSH) diabetcs mellitus, 
type 2 or diahetes mellitus or prediabetic 
state or metabolic syndrome X or glu-
cose intolerance or hyperglycemia or 
glucose metabolism disorders or i11sulin 
resistancc or glucose tolera11ce test or 
text worcls insu!in sensitivity or 
impaircd fasting glucose or impaired 
glucose tolcrcmce or IGT or IFG. The 
second thcme, smoking, combined 
exploclecl versions of MeSH tenus 
smohing or smohing cessation or smohe 
inhalation i11jwy or tobacco, smoheless 
or tobacco 11se cessation or tobacco use 
disorder or tobacco or nicotine or text 
worcls nicotine dcpendence or tobacco 
dependence or smolling depe11de11ce or 
cigarette* The thircl theme, stuclies 
vvith a prospective design, combinecl 
exploded versions of MeSH terms inci-
dence or cohort studies or follow-11p 
studies or prog11osis or carly diagnosis 
or survival analvsis or text words 
course or predict* -or prognos*. Because 
we focusecl on original studies and 
observational cohort studies, we 
excluclecl other design types using the 
Boolean operator "not": meta-analysis 
(MeSH tenu) or rcview (publication 
type) or case-control studies (MeSH 
term). No previous meta-analyses 
were iclentifiecl. 
Selection Criteria 
Two reviewers (CW. and P.B.) iclenti-
fied articles eligible for further review 
by performing an initial screen of 
identified abstracts or titles. Articles 
were consiclered for inclusion in the 
systematic review if they reportecl data 
from an original study (ie, no revicw 
articles) and reportecl the incidence of 
impairecl fasting glucose, glucose 
intolerance, or type 2 diabetes in 
active cigarette smokers. We used 
broacl inclusion criteria for stuclies, 
inclucling ail spectra of glucose abnor-
mality (from impairecl fasting glucose 
to diabetes type 2) and smoking sta-
tus. The observed agreement between 
reviewcrs for eligibili ty of articles on 
this first screening was 94.6°/,,, corre-
spond i ng to moclest agreement 
(1<=0.40). Articles were retained when 
either of the 2 reviewers believecl that 
it shoulcl be relainecl. 
The second screening was based on 
full-text review. To be includecl, stud-
ies hacl to be cohort studies (prospec-
tive cohort or historical cohort) with an 
aclult population (2::16 years) ex-
posed to active cigarette smoking and 
a comparison group of nonsmokers. 
One of the outcomes hacl to be the in-
cidence of impaired glucose toler-
ance, impaired fasting glucose, or type 
2 cliabetes. Exclusion criteria were stud-
ies that inclucled participants with clia-
betes at the beginning of the stucly or 
that used an inappropriate compari-
son group (a comparison group that 
was not nonsmokers or former smok-
ers). The agreement between review-
ers for eligibility of articles was 96.0%, 
with a K of0.86. Any clisagreement was 
resolved by consensus. 
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Data Extraction 
The key exposure variable was the pres-
ence or absence of active smoking at 
baseline, and the preferred reference 
group was "never smokers." The ma-
jority of studies (n= 18) definecl a group 
of former smokers but 7 studies di-
chotomized the exposurc variable 
(smokers vs nonsmokers) without men-
tioning w hether the nonsmoking group 
included former smokers. We consicl-
erecl this heterogeneous groupas non-
smokers in the poolecl analysis and per-
fonned a sensitivity analysis that only 
inclucled studies with a reference group 
defined as strictly never smokers. 
The outcome variable of intercst was 
defined as the presence or absence of 
type 2 cliabetes, impairecl fasting glu-
cose, glucose intolerance, or a combi-
nation of these. The de finitions and di-
agnostic proceclures usecl to clefine this 
outcome varied somewhat across stud-
ies because of the clifferent countrics 
and periods in which the studies were 
pcrformecl. The American Diabetes As-
sociation and the Worlcl Health Orga-
nization now share iclentical diagnos-
tic criteria for type 2 diabetes 1° but 
definitions have changed over time. 
Moreover, the prevalence of cliabetes 
can change as a fonction of diagnostic 
criteria usecl. 11 The criteria used in the 
studies retrieved incluclecl the Worlcl 
Health Organization 1985 criteria 12 
(fasting glucose threshold 2:: 140 mg/ 
dL; to convert glucose to mmol/L, mul-
tiply by 0.0555), the Worlcl Health Or-
ganization 1999 criteria 13 or the 
Amcrican Diabetes Association 199714 
criteria (fasting glucose threshold 2:: l 26 
mg/dL), or other criteria (fasting glu-
cose threshold 2:: 110 mg/dL or 2:: 120 
mg/dL). 
In ail analyzed studies, participants 
were screened for diabetes al baseline 
and excluclecl if found to have diabe-
tes. However, baseline dia be tes screen-
ing methods also varied across studies 
and couic! be a biological screening 
(blood tests or urine analysis), patient 
report, or physician report. The meth-
ocls usecl to screen for glucose metabo-
lism irregularities in the follow-up pe-
1iods variecl across stuclies and includecl 
©2007 Amcrican Mcdical Association. Ali rights rcservcd. (Reprinted) JAMA, Dccembcr 12, 200ï-Vol 298. No. 22 2655 
RISK OF TYPE 2 DIABETES IN SMOKERS 
Figure 1. Flowchart of Meta-analysis 
2246 Cnations identified from 1 1 Article identified from reference lists 1 literature search 
1340 From MEDLINE 
906 From EMBASE 
~12098 Cnations excluded based on screening 
of tit!es or abstracts using general criteria 
149 Potentially relevant articles identified 
for further review 
124 Articles excluded atter full-text review 
88 No relative risk of diabetes for smokers 
17 Outcome was not diabetes 
____,_ 13 Design was not correct 
3 Outcome was gestational diabetes 
2 Same cohort previously analyzed 
1 Participant with diabetes at baseline 
25 Articles included in meta-analysis 
1 (1.2 million study participants) 
a biological screening, participant's re-
port with or without confirmation (by 
physician, rcgistry, or subsequent bio-
logical testing), or physician's report 
with or without confirmation (by reg-
istry or biological testing). 
We then extracted any reported rela-
tive risks (RRs), hazard ratios, odds ra-
tios (ORs), or incidence density ratios 
for the risk of developing diabetes or 
other glucose metabolism irregulari-
ties for active smokers comparecl with 
nonsmokers. Bo th unacljustecl and ad-
jusled values were extracled for these 
measures of risk. If available, we ex-
tracted any reported risks of diabetes 
for former smokers compared with 
never smokers and for heavy smokers 
and lighler smokers comparecl with 
never smokers. 
We also extracted information on key 
indicators of study quality, using the 
Meta-analysis of Observational Stud-
ies in Epidemiology (MOOSE) stan-
dards 15 for reporting of meta-analyses 
of observational studies. We consid-
ered inclusion of conseculive partici-
pants in a cohort (ail participants pre-
senting with study inclusion criteria 
during a specific periocl should be in-
cl ucled in a cohort), follow-up clura-
tion (the cluration should be long 
enough to allow for a latent period), 
blinding study personnel evaluating key 
outcomes to exposure status, and sta-
tistical adjustment for the main con-
founding factors of interest (sex, so-
cioeconomic level, physical activity, age, 
obesity, diet, ethnicity, increased waist 
circumference, alcohol consumption, 
heredity, hypercholcsterolemia, blood 
pressure, fasting blood glucose, comor-
bidities, and use of antihypertensive 
clrugs). 
Statistical Analysis 
The RRs were used as the common 
measure of association across stuclies. 
To do this, the hazarcl ratios and inci-
dence density ratios were directly con-
sidered as RRs. The ORs were trans-
formed into RRs using the formula 
RR=ORl[(l-P 0 )+(P0 X OR)], in which 
P0 is the incidence of the outcome of 
interest in the nonexposed group. 16 This 
method of transformation has some 
limitations and can underestimate the 
variance of the RRs derived frorn the 
ORs. n.is We therefore perfonned a sen-
sitivity analysis that excluded the 5 
stuclies in which this transformation 
was pcrformed. Wc also compared the 
results applying the Miettinen test-
based approach 19 for calculating 
the variance of the lnRR (variance 
lnRR=variance ln OR X [lnRR/lnOR]). 
Meta-analysis was performed using 
Stata version 9.1 (StataCorp, College 
Station, Texas). We used the "rnetan" 
command in Stata to pool the lnRR 
across studies using the DerSimonian 
and Laird random-effects model. 2° For-
est plots were used to visually assess the 
RR estimates and corresponding 95% 
confidence intervals ( Cls) a cross stud-
ies. Analyses were stratified by study 
quality criteria and by participant 
c harac teristics. 
To assess for heterogeneity of RRs 
across studies, the Cochrane Q statis-
tic (significance lcvel of Ps .10) and 
the 12 statistic were calculated. 21 •22 
Meta-regression and sensitivity analy-
sis were perforrned to assess the 
effeets of selected study quality and 
clinical factors on diabetes risk. 
The possibility of publication bias 
was assessed using the Begg test and vi-
sual inspection of a funnel plot. 23-"·1 We 
also perfonned the Duval and Tweedie 
nonpararnetric "trim and fil[" proce-
clure to further assess the possible 
effect of publication bias in our rneta-
analysis.21 This rnethod considers the 
possibility of hypothetical "missing" 
studies that might exist, imputes their 
RRs, and recalculates a pooled RR that 
incorporates the hypothetical rnissing 
studies as though they actually ex-
isted. 
RESULTS 
Literature Search 
The search strntegy retrieved 2246 
unique citations: 1340 frorn MEDLINE 
and 906 frorn EMBASE. Of these, 2098 
citations were excluded after the first 
screening basecl on abstracts or titles, 
leaving 148 articles for full-texl re-
view (FIGURE 1 ). I-Iancl searching of the 
bibliographie references of these ar-
ticles identifiecl 1 additional article, for 
a total of 149 articles for full-text re-
view. On this review, 124 articles were 
ex cl uded for the reasons lis te cl in 
Figure 1, leaving 25 studies for final in-
clusion in the systematic review and 
meta-analysis. 
Two supplernentary studies were 
identified that hacl been published 
only as abstracts from conference pro-
ceedings of scientific meetings. 25 •26 
They were not included in the poolcd 
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Table 1. Characteristics of Studies lncluded in the Meta-analysis 
Diabetes 
Incidence Diabetes Incidence by FGT 
(Cases/ Smoking Status, Used for Base li ne 
Total 1000 No.!Total Diabetes Diabetes Maximum 
No.of Person- Diabetes Detection, Screening Follow-up, 
Source Cohort Designation Patients Years), % Current Non Former Measure mg/dl Method y 
Cassano et al, 31 Normative Aging Study 19728 NA 76/ 51/ 98/ Biologically 2:140 Biological 26 
1992 Cohort of Veterans 708 569 690 screened screening 
Perry et al, 32 British Regional 7577 8 2.2 b; b/ b; Patient NA Biological 13 
1995 Heart Study 3125 1787 2649 reported screening 
Rimm et al,33 Healtl1 Professional's 39745 2.2 55b/ 188b/ 239b; Patient 2:140 Patient 6 
1995 Follow-up Study 3585 19386 16774 reported questionnaire 
Kawakamiet Japanese cohort of 2312 2.2 b; b; b; Biologically 2:140 Patient 8 
al,"11997 male employees 1420 583 309 screened questionnaire 
Njolstad et al,3" Cardiovascular 11654 1.2 67/ 95/ NA Registry NA Biological 12 
1998 Disease Study 5921 5733 consultation screening 
or patient 
reported 
Sugimori et al,86 Database accumulated 2573 NA b b Biologically 2:110 Biological 16 
1998 from MHTS screened screen1ng 
Uchimotoet Osaka Health Survey 6250 7.4 302/ 79/ 69/ Biologically 2:126 Biological 16 
al,3 ' 1999 3880 1302 1068 screened screening 
Strandberg et Helsinki Business 1802 2.4 b; b; b; Mixed 2:120 Biological 20 
al,38 2000 Study 550 608 644 methods screening 
Nal<anishi et Japanese male office 1266 9.1 42/ 71 5/ Biologically 2:126 Biological 5 
al,'" 2000 workers 646 407 213 screened screening 
Manson et al,"' Physician's Health 21 068 3.0 127/ 323/ 320/ Patient NA Patient 12 
2000 Study 2229 10511 8258 reported questionnaire 
Will et al,41 2001 Cancer Prevention 709827 3.8 8661/ 13312/ 3424/ Physician NA Patient 13 
Studyl 274558 346060 89209 reported questionnaire 
Wannamethee Britisl1 Regional 6397 2.7 127b/ 47b/ 32b; Patient 2:140 Biological 18 
et al:" 2001 Heart Study 2942 1541 1914 reported screening 
Hu et al,21 2001 Nurse's Health Study 84941 2.5 620b/ 1445b; 1217b; Patient 2:140 Patient 16 
NA NA NA reported questionnaire 
Montgomery British National 4917 NA 15/ 13/ NA Patient NA Medical 17 
and Child Development 1666 3251 reported examination 
Ekbom,43 Study and record 
2002 reviews 
Sawada et al ,'14 Male Employees 4745 4.3 b; b; b Biologically 2:126 Biological 14 
2003 Cohort 3190 1555 screened screening 
Sairenchi et al;"' Japanese who 128141 13.0 b b Biologically 2:126 Biological 9 
2004 underwent health screened screening 
checkups 
Carlsson et al, 40 Nord-Trondelag 38805 NA 170/ 365/ 203/ Patient 2110 Patient 11 
2004 Health Survey NA NA NA reported questionnaire 
Eliasson et al ,'17 Northern Sweden 1275 2.4 8/ 71 12/ Patient 2:126 Patient 13 
2004 MONICA Study 235 761 279 reported questionnaire 
Lyssenl<o et Botnia study 2115a NA b/ b/ b Biologically 2:126 Biological 12 
al, 48 2005 799 1277 screened screening 
F'atja et al,'" 4 surveys in Finland 41372 3.3 799/ 1567/ 404/ Registry NA Patient 30 
2005 12498 22957 5917 consultation questionnaire 
Waki et al,"° JPHC Study 28893 NA 391/ 586/ 206/ Patient NA Patient 10 
2005 7363 18338 3192 reported questionnaire 
Tenenbaum et Benzafibrate lnfarctirn1 630 NA 18/ 32/ 48/ Biologically 2126 Biological 9 
al, 51 2005 Prevention Study 78 195 357 screened screening 
Foy et al," lnsulin Resistance 906 NA 32/ 60/ 56/ Biologically 2:140 Biological 5 
2005 Atherosclerosis Study 128 424 354 screened screening 
Meisinger et MONICA/KORA Augsburg 10892 5.5 187/ 268/ 217/ Patient NA Patient 18 
al,28 2006 Cohort Study 2866 4951 3075 reported questionnaire 
Houston et al,'" CARDIA Study 4572 3.1 c NA/ NA/ NA/ Biologically 2:126 Biological 15 
2006 1386 2565 621 screened 
Abbreviations: CARDIA, Coronary Artery Risk Develop111ent in Young Adults: FGT, lasting glucose threshold; JPHC, Japan Public Health Center: KORA, Cooperative Research in the 
Region of Augsburg; MONICA, Monitoring Trends and Deterrni11ar1ts of Cardiovascular Disease; MHTS. Multiphasic Health Testing and Se1vices: NA, not recorcled or available. 
SI conversion factor: T o convert glucose to rrnnol/L, 111ultiply by 0.0555. 
aooes not equal total for diabetes incidence by s111oking status due to missing data. 
bMissing data by category. There were a total of 194 new cases of diabetes for Perry et al: 509101 Ri111m et al: 41 for KawaJ<ami et al: 296 for Sugimori et al: 94 for Strandberg et al; 3300 
for Hu et al; 280 foi· Sawada et al: 7990 for Salrenchi et al; and 127 for Lyssenko et al. 
c Incidence at 15 years deriveci from Kaplan-Meier analysis. 
©2007 Amcrican Mcclical Association. Ali rights rcservctl. (Reprinted) JAMA, Dccernbcr 12, 2007-Vol 298, No. 22 2657 
Downloaded from at Centre Hospitalier Universitaire, on December 17, 2007 
RISK OF TYPE 2 DIABETES IN SMOKERS 
analyses because of lack of cletails on 
key stucly variables and because of 
stucly quality. Risks were given for 
subgroups of smokers (heavy and 
lighter smokers) and were higher for 
smokers vs nonsmokers. However, 
there were nol sufficient data to calcu-
la Le a mean risk for smokers and 
Lherefore they couic! not be includecl 
wiLh oLhcr studies in sensitivity 
analyses. 
The review iclcnlifiecl 2 articles that 
were basecl on ovcrlapping data from 
the Nurses' Health stucly27 ·28 and 2 ar-
ticles that were basecl on overlapping 
data from the Monitoring Trends and 
Dcterminants of Cardiovascular Dis-
ease (MONICA) Augsburg cohort 
study.29.3° We avoided cluplicate inclu-
sion of data by selecting only the more 
complete article from each cohort. 
Study Charac:terisfü:s 
Characlerislics of the 25 selectecl stucl-
ies are shown in TABLE l. 27·29·31-53 Ail 
were prospective cohort studies. Ail 
studies reportccl the incidence of dia-
betes as an outcome of interest excepl 
1 stucly53 Lhat reported the incidence of 
a composite outcome (diabetes and/or 
impaired fasting glucose). The associa-
tion betwecn smoking and diabetes was 
the primary outcome of interest for 16 
studies, whereas il was a secondary 
question in 9 studies. 
Diabetes was screened with biologi-
cal measures in 11 studics, was re-
ported by patients or physicians in 11 
studies, and was cletermined by other 
methocls (hospital meclical registries, 
insurancc rcgistries) in 3 studies. 
Rcgarcling eut-point clcfinitions for 
diabetes, 6 stuclies used a fasting glu-
cose threshold of 140 mg/dL or 
higher, 8 studies used a threshold of 
126 mg/c\L or higher, 1 slucly usecl a 
thresholcl of 120 mg/c\L or higher, 2 
sludies used a Lhresholcl of 110 mg!dL 
or highcr, and 8 studies did nol 
explicitly mention the criteria that 
they usccl. Screening for diabetic par-
ticipants at baseline was performed 
using a biological screening for 14 
stuclies and by asking patients or phy-
sicians for the other 11. 
The selectecl studies were pub-
lished between 1992 and 2006, and the 
number of participants per study ranged 
from 630 to 709 827, for a Lota! of 1.2 
million participants across studies 
( 45 844 incident cases of dia be tes). 
Seven studies were concluctecl in the 
United States, 7 injapan, 6 in Scandi-
navian countries, 3 in the United King-
dom, 1 in Germany, and l in Israel. 
Eleven stuclies involved men only, 1 
study involvecl only women, and the 
other 13 studies incluclecl both men and 
women. Mean body mass index (BMI; 
calculated as \veight in kilograms di-
vicled by height in meters squarecl) of 
participants ranged from 22.3 to 28.4 
and mean age at baseline varied from 
16 Lo 60.7 years. The percentage of 
smokers ranged from 9% to 67% and 
the pooled percentage of smokers was 
35%. 
The cohort stucly quality criteria of 
blinding to ascertain outcome and re-
cruiting consecutive patients were not 
explicitly specifiecl in any of the stucl-
ies that we selectecl. Follow-up rangecl 
from 5 to 30 years; average (mean or 
meclian) follow-up duration was given 
for only 9 studies. The frequency of fol-
low-up was at least once per year for 9 
stuclies, once every 2 years for 4 stucl-
ies, and at baseline and the end of the 
study for the remaining 12 stuclies. The 
proportion of palients with complete 
follow-up to the end of the stucly was 
given for 17 studies and rangecl from 
69.2'){, to 99.7%. 
Acljusted RRs couic\ be determined 
for ail stuclies, either as reported or by 
conversion from ORs (TABLE 2). Most 
risk measures werc adjusted for age (22 
studies) and BMI (22 stuclies); fewer 
wcre adjustecl for physical activity (13 
stuclies), alcohol consumption (14 stud-
ies), hcreclity (10 stuclies), education (6 
studies), diet (2 studies), or waist cir-
cumferencc (3 studics). 
Risi< of Diabetes for Smol<ers 
Compared With Nonsmol<ers 
Among the 25 selecLecl studies, alî but 
one35 found an association between ac-
tive smoking and an increasecl risk of 
cliabetes, although not ail were statis-
tically significant. Three studies re-
ported unadjustecl RRs·13•52•51 ; the pooled 
crucle RR estimate from these studies 
was 1.89 (95% CI, 1.58-2.27). Ail 25 
studies proviclecl acljusted risks ex-
pressed as RRs, hazard ratios, inci-
dence density ratios, or ORs, and the 
clerivecl full y adjustecl RRs ranged from 
0.82 Lo 3. 7 4. Ac Live smokers hacl an in-
creased risk of cleveloping type 2 dia-
betes comparecl with nonsrnokers, with 
a poolecl RR of 1.44 (95°/c, CI, 1.31-
1.58) (FIGURE 2). 
A sensitivity analysis that excludecl 
all studies for which the OR to RR 
conversion was usecl had a similar 
result, with a poolecl RR of 1.44 (95% 
CI, 1.30-1.59). Using the test-based 
approach by Miettinen19 to calculate 
the variance resultecl in essentially 
iclentical resulls (RR, 1.44 [95% CI, 
1.31-1.58]). In a sensitivity analysis 
Lhat incluclecl only the 18 stuclies in 
which the comparison was defined as 
strictly nonsmokers (without former 
smokers), the pooled RR was 1.45 
(95% CI, 1.31-1.62). 
There was evidencc of statistical 
heterogenei ty of RRs a cross studies ( Q 
statistic, 98.08; P< .001; I2, 75.5%). 
These measurements of heterogeneity 
were likely driven by the extremely 
large overall number of participants in 
our analysis (> l million). The point es-
Limates of the RRs were consistcntly 
greater than 1 in ail but 1 study, and 
stucly subgroups were more homoge-
neous. 
Stratified Analyses 
To explore the study heterogeneity, we 
performed stratified analyses across a 
nurnber ofkcy study characteristics and 
clinical factors (TABLE 3). The finding 
of increasecl cliabetes risk in smokers 
was consistently founcl in all of the 
stratified analyses. Stucly quality char-
acteristics did not seem to markedly in-
fluence the results, although studies that 
met more quality criteria tendecl tore-
port a slightly stronger association of 
smoking with diabetes incidence. For 
example, stronger associations be-
tween smoking and diabetes inci-
dence were found in stuclics that were 
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adjusted to 8 or more confounding fac-
tors, if smoking and incidence of dia-
bctcs was the primary outcome, and if 
a biological screcning for diabetes was 
pcrformed at basclinc (Table 3). 
The characteristics of participants 
included in the primary studies also 
seemed to be associated with the 
results. For example, studies reportecl 
a stronger association between smok-
ing and diabetes incidence if they 
incluclecl olcler participants (mean age 
of participants, 2:50 years) or when 
the participants tencled to be over-
weight or obese (mean BMI of partici-
pants, 225) (Table 3). In studies that 
included both men and women, the 
pooled iisk was similar in both sexes 
(pooled RR of 1.28 [95% CI, 1.12-
1.45] for men and 1.25 [95% Cl, 1.06-
1.65] for women). 
Table 2. Confounding Factors and Methods for Adjustment 
Source 
Cassano et al,31 1992 
Perry et al," 1995 
Rimm et al,"'1 1995 
Kawakarni et al,24 1997 
Njolstad et al,85 1998 
Sugimori et ai,''6 1998 
Uchimoto et al,'l7 1999 
Strandberg et al,'" 2000 
Nakanishi et al,30 2000 
Manson et al, 41' 2000 
Will et al,'11 2001 
Wannarnethee et al,42 
2001 
Hu et al,27 2001 
Montgomery and 
Ekbom,'13 2002 
Sawada et al,44 2003 
Sairenchi et al,45 2004 
Carlsson et al,46 2004 
Eliasson et al, 47 2004 
Lyssenko et al, 48 2005 
Patja et al;10 2005 
Waki et al,w 2005 
Tenenbaum et al, 51 
2005 
Foy et al," 2005 
Meisinger et al,29 2006 
Houston et al,53 2006 
Method for Adjustment 
Proportional hazards regression 
Proportional hazards regression 
Multiple logistic regress1on 
Proportional hazards regression 
Proportional hazards regression 
Proportional hazards regression 
Proportional hazards regression 
Multiple logistic regression 
Proportional hazards regression 
Proportional hazards regression 
Proportional hazards regression 
Proportional hazards regression 
Multiple logistic regression 
Multiple logistic regression 
Prop01iional hazards regression 
Proportional hazards regression 
Multiple logistic regression 
Multiple logistic regression 
Proportional hazards regression 
Proportional l1azards regression 
Multiple logistic regression 
Proportional hazards regression 
Multiple logistic regression 
Proportional hazards regression 
Proportional hazards regression 
Risk 
Expression 
HR 
RR 
RR 
HR 
RR 
HR 
RR 
RR 
RR 
RR 
IDR 
RR 
RR 
OR 
RR 
RR 
OR 
OR 
HR 
HR 
OR 
HR 
OR 
HR 
HR 
Confounding Factors 
Age, BMI, waist circumference 
Age, BMI, blood pressure, triglycerides, HDL cl1olesterol, heart rate, 
uric acid 
Age, herecity, BMI, pl1ysical activrty, alcohol consumption 
Age, heredrty, education, BMI, physical activity, alcohol consumption, 
occupation, type of work shift 
Age, ethnicrty, blood pressure, pl1ysical activrty, total cholesterol, 
triglycerides, HDL cholesterol, antihypertensive treatment, heigl1t, 
glucose 
Age, l1eredrty, BMI, blood pressure, alcol1ol consumption, total 
cholesterol, lasting glucose, eating breakfast, uric acid, dairy intal<e 
Age, heredity, BMI, physical activity, alcohol consumption, total 
cholesterol, triglycerides, HDL cholesterol, lasting plasma 
glucose, l1ematocrit 
BMI, blood pressure, triglycerides 
Age, herecity, BMI, blood pressure, physical activity, alcohol 
consumption, total cholesterol, triglycerides. HDL cholesterol, levels 
of lasting plasma glucose, uric acid, l1ematocrit 
Age, BMI, blood pressure, physical activity, alcohol consurnption. total 
cholesterol, parental l1istory of myocardial infarction before age 60 
years, treatment assignment 
Age, ethnicity, education, BMI, physical activity, diet, alcol1ol 
consurnption 
Age, education, BMI, pliysical activrty, alcohol consumption, 
ar1tihyperte11sive treatrnent, preexisting coronary heart disease 
Age, l1eredity, study period, menopausal status, use of postmenopausal 
hormone therapy 
Sex, BMI, maternai smoking during pregnancy, age mother left school, 
birth weight, mother's age at birth, farnily social class at birth 
Age, l1eredity, BMI, blood pressure, alcot1ol consumption 
Age, herecrty, BMI, blood pressure, total cholesterol, triglycerides, HDL 
cholesterol, antil1ypertensive treatment, lasting glucose status 
Sex, age, BMl 3 
Age, BMI, follow-up duration 
BMI 
Sex, age, education, BMI, blood pressure, physical activity, alcohol 
consumption, coffee consumption, study year 
Age, l1eredrty, BMI, blood pressure, physical activity, alcohol 
consumption 
Sex, age, BMI, blood pressure, total cholesterol, triglycerides, presence 
of NYHA Ill functional class, glucose, previous myocardial infarction, 
peripheral vascular disease, anginal syndrome, bezafibrate treatment 
Sex, age, ethnicity, BMI, waist circumference, blood pressure, physical 
activity, alcohol consumption, triglycerides, HDL cholesterol, clinic, 
glucose tolerance status 
Age, heredity, education, BMI, blood pressure, physical activity, alcohol 
consumption, total cholesterol, triglycerides, HDL cholesterol, survey 
Sex, age, ethnicrty, education, waist circumference, blood pressure, 
physical activity, diet, alcol1ol consumption, triglycerides, C-reactive 
protein, insulin concentration, health insurance 
Abbreviations: BMI, body mass index; HDL, !1igh-density lipoprotein; HR, hazard ratio; IDR, incidence density ratio; NYHA, New York Heart Association; OR, odds ratio; RR, relative risk. 
8 Results persisted after adjustment for age, BMI. physical activity, alcohol consurnptior1, and education. 
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Figure 2. Adjusted Relative Risks of Diabetes for Current Smokers Compared With 
Nonsmokers 
Weight, % (Random Relative Risk 
Source Effects Modal) (95%CI) 
Cassano et al,31 1992 3.88 1.50 (1.07-2.1 O) 
Peny et al,32 1995 3.16 1.20 (0.80-1.80) 
Rimm et al,33 1995 2.59 1.88 (1.17-3.02) 
Kawakami et al,34 1997 0.62 2.38 (0.77-7.40) 
Njolstad et al,35 1998 2.69 0.82 (0.52-1.30) 
Sugimori et al,36 1998 4.97 1.42 (1.10-1.83) 
Uchimoto et al,37 1999 4.78 1.47 (1.13-1.92) 
Strandberg et al,38 2000 2.62 1.62 (1.01-2.59) 
Naikanishi et al,39 2000 0.84 2.74 (1.05-7.13) 
Manson et al,40 2000 7.42 1.63 (1.50-1.77) 
Will et al,41 2001 7.69 1.13 (1.07-1.19) 
Wannamethee et al, 42 2001 3.91 1.74 (1.25-2.43) 
Hu et al, 27 2001 6.92 1.30(1.15-1.47) 
Montgomery and Ekbom,43 2002 0.46 2.47 (0.66-9.30) 
Sawada et al,44 2003 4.44 1.24 (0.93-1.66) 
Sairenchi et al,45 2004 6.80 1.35 (1.18-1.54) 
Carlsson et al,46 2004 5.71 1.06 (0.86-1.30) 
Eliasson et al,47 2004 0.53 3.74 (1.08-12.91) 
Lyssenko et al,48 2005 3.88 1.50 (1.07-2.10) 
Patja et al,49 2005 6.85 1.46 (1.28-1.66) 
Waki et al,60 2005 5.58 1.31 (1.06-1.62) 
Tenenbaum et al,51 2005 2.30 1.94 (1.16-3.25) 
Foy et al,52 2005 3.52 2.15 (1.49-3.11) 
Meisinger et al, 29 2006 2.90 1.62 (1.05-2.50) 
Houston et al,53 2006 4.94 1.65 (1.28-2.13) 
Overall 100.00 1.44 (1.31-1.58) 
(12 =75.5%; P<.001 forQ statistic) 
Relative Risk (95% Cl) 
Cl indicates confidence interval. Size of data markers indicates the weight of the study. 
The stratified analyses shown in 
Table 3 suggesl a dose-response rela-
Lionship beLween smoking and cliabe-
Les. The associalion between smoking 
and diabetes was slronger for heavy 
smokcrs (2':20 cigarettes/day; RR, 1.61 
[95% CI, 1.43-1.80]) comparecl with 
lighter smokers (RR, 1.29 [95% CI, 
1.13-1. 48]). The association also was 
weaker for former smokers (RR, 1.23 
[95% CI, 1.14-1.33]) than it was for ac-
tive smokers. 
The association between smoking 
and diabetes was slightly stronger if 
there was a biological screening for dia-
beles during follow-up (RR, 1.49 [95% 
CI, 1.35-1.63]) compared wilh cases re-
ported by patient or physician (RR, 1.39 
[95% CI, 1.20-1.62]). The association 
between smoking and diabetcs was also 
stronger for the 6 studies in which a glu-
cose threshold of 140 mg/dl or higher 
was used (RR, 1.63 [95% CI, 1.33-
1.99]) compared with 8 studies in 
which a glucose threshold of 126 mg/cil 
or higher was used (RR, 1.4 7 [ 95% CI, 
1.30-1.65]). In a sensilivity analysis of 
the 24 studies that reported only on the 
incidence of diabetes (exclucling the 1 
study that evaluatecl the risk of im-
paired glucose tolerance53), the over-
all poolecl result did not change (RR, 
1.43 [95% CI, 1.30-1.57]). 
Publication Bias 
Visual inspection of the Begg funnel plot 
revealecl asymmetry (P < .001) 
(FIGURE 3A). This mises the possibil-
ity of publication bias, although the 
Begg tesl was not slatisitically signifi-
canl (z= 1.45; P=.15). Because of Lhis, 
we undertook a sensitivity analysis 
using the trim and fill methocl,5'1 which 
conservatively imputes hypothetical 
negative unpublishecl sLu<lies to mir-
ror the positive studies that cause fun-
nel plot asymmetry. The imputed stud-
ies produce a symmetrical funnel plot 
(Figure 3B). The poolecl analysis in-
corporaling the hypothetical sLudies 
conlinued to show a statistically sig-
nificant association between smoking 
and diabetes (RR, 1.32 [95% CI, 1.21-
1.44]; P<.001). 
COMMENT 
There is an exlensive body of liLera-
Lure reporting on the association be-
tween active cigarette smoking and the 
incidence of diabetes. The 25 studies 
that we identified report RRs that, while 
somewhat variable in magnitude, indi-
cate a positive association in ail but 1 
study. Furthennore, the association per-
sists and remains statistically signifi-
cant across a number of stratified analy-
ses exploring clinical and study quality 
factors, and also persists in sensitivity 
analyses performed to assess the po-
Lential effect of varying diabetes out-
come clefinitions and hypothetical un-
p u b lis h e d stuclies. Given this 
consistency, we conclucle that the rel-
evant question shoulcl no longer be 
wheLher this associalion exists, but 
raLher whether this establishecl asso-
ciation is causal. 
Observational primary studies can-
not prove causality. However, the stucl-
ies in this review do meet several of the 
Hill criteria 55 for causation. First, there 
is an appropriate temporal relation-
ship: the cigarette smoking prececled 
diabetes incidence in ail stuclies. Sec-
ond, the finclings are consistent wilh a 
dose-response relationship, with slron-
ger associations for heavy smokers rela-
tive to lighter smokers and for aclive 
smokers relative to former smokers. 
However, an observed close-response 
relationship can arise from the inten-
sity of clustering with other cliabetes 
risk factors such as Jack of physical ac-
tivity and unhealthy diet. Thircl, there 
is theoretical biological plausibility for 
causaliLy in Lhat smoking may lead to 
insulin resistance or inadequate com-
pensatory insulin secretion responses 
according to several56-61 but not all62 
studies. Smoking also has a clinically 
significant effect on both oral and in-
travenous glucose tolerance tests that 
couic! influence cliabetes de.tee-
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tion.60·63-65 This could be due to a di-
rect effect of nicotine or other compo-
nents of cigarette smoke on beta cells 
of the pancreas, as suggested by the as-
sociation of cigarette smoking with 
chronic pancreatitis and pancreatic can-
cer.66 Fourth, there is consistency of this 
association across 24 studies, as shown 
by the forest plot (Figure 2). Fifth, the 
strength of the association with diabe-
tes is not negligible in the context of to-
bacco research. 
Conversely, there are also possible 
noncausal explanations for this asso-
ciation. Smoking is often associated 
with other unhealthy behaviors that 
Table 3. Stratified of Pooled Relative Risks of Diabetes for Smokers 
Total No. 
Pooled RR 
Stratified Analysisa Trials Patients (95% Cl) 
Study Quality Characteristics 
Adjustment for confounding factors 
Minimal 13 933 738 1.32 .19-1 
Substantial (28 factors) 12 231636 1 .52 (1 .38-1.68) 
Incidence of diabetes as the primary outcome 
Yes 16 1.1 million 1.50 (1.33-1.69) 
No 9 66248 1 .34 (1.20-1.49) 
Type of outcome measurec 
Biologically measured 11 865309 1 .49 (1.35-1 .63) 
Patient or physician reported 11 955064 1.39 (1.20-1 .62) 
Other 3 54828 1 .29 (0.91-1.82) 
Type of screening for diabetes at baseline0 
Biological screening 14 181327 1.47 (1.33-1.63) 
Patient questionnaire 10 984047 1.39 (1.20-1.61) 
Other 4917 2.47 (0.65-9.30) 
Fasting glucose threshold, mg/dl 
2140 6 137000 1 .63 (1 .33-1.99) 
2126 8 148994 1.47 (1.30-1.65) 
2120 1 1802 1.62 (1.01-2.59) 
2110 2 41 378 1.22 (0.91-1.62) 
Nonspecified (reference) 8 836200 1.33 (1.11-1.59) 
Mean follow-up, y 
~10 9 216175 1.70 
>10 15 942949 1.35 (1.21-1.51) 
Patient Characteristics 
Mean body mass indexe 
<25 8 813427 
225 10 112363 
Mean age, y 
<50 15 163103 
?:50 5 772176 
Smoker type 
Heavy (220 cigarettes/ci) 6 154165 
Light ( <20 cigarettes/ci) 6 154165 
Former vs never smokers 17 1.1 million 
Active smokers vs nonsmokers 25 1.2million 
Sex9 
Men 7 932894 
Women 7 932894 
Abbreviations: Cl, confidence interval; NA. not applicable because only 1 study; RR, relative risk. 
SI conversion factor: To convert glucose to mmol/L, multiply by 0.0555. 
a Relative risks adjusted for the most variables are tai<en for each study. 
b Represents the test for the significance of the elfect modification across strata. 
c Metaregression was perforrned for tl1e first 2 categories. 
d No P values were given for this group. 
ecalculated as weight in kilograrns divided by height in meters squared. 
f Meta-regression was not possible. 
9 lncluded only studies with a population of botl1 men and women. 
1.34 (1.13-1.58) 
1.57 (1.35-1.82) 
1.39 (1 .26-1 .54) 
1 .62 (1.24-2.13) 
1 .61 (1.43-1.80) 
1.29 (1.13-1.48) 
1.23 (1.14-1.33) 
1.44 (1.31-1.58) 
1.28 (1.12-1.45) 
1 .25 (1 .06-1.46) 
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favor weight gain and/or diabetes, 
such as lack of physical activity, poor 
fruit and vegetable intake, and high 
alcohol intake. 67·68 Furthermore, this 
clustcring of behaviors is more preva-
lent in individuals of lower sociocco-
nomic status. 69•70 Sorne of these fac-
tors were considered and adjusted for 
PValue 
Meta-
Heterogeneity regression b 
.01 J <.001 .04 
<.001 J 
.001 
.49 
30 J 
<.001 <.001 
.05 
.13 J 
<.001 <.001 
NA 
.06 .13 
.30 .27 
NA .53 
.08 .62 
.002 d 
.14 J <.001 
<.001 
<.001 J <.001 
.11 
.09 J <.001 
<.001 
36 
" ] <.01 
<.001 
.02 J .02 
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in the studies included in our revkw, 
but the extent to which these poten-
tial intervening factors were con-
trolled for in the individual studies 
was generally limited. The Jack of 
adjustment for socioeconomic status 
(only 6 stuclies adjustecl for socioeco-
nomic status or eclucation), diet (only 
2 stuclies), physical activity (only 13 
studies), and alcohol consumption 
(only 14 studies) could contribute to 
a noncausal association between 
smoking and diabetes. 
Smokers tend to be thinner than 
nonsmokers or former smokers, and 
several studies have shown that smok-
ers' BMI is lower. 71 -73 However, there is 
eviclence that smokers (especially 
heavy smokers) tend to have higher 
BM!s than lighter smokers and even 
some nonsrnokers. 7'1 In addition to a 
clustering of risky behaviors, this find-
ing couic\ be due to the weight cycling 
phenomenon. Smokers tend to gain 
weight when Lhey quit smoking; the 
stronger the clepenclence, the greater 
the risk of relapse. 75 •76 Therefore, 
heavy smokers may need several 
attempts before they definitively quit 
smoking, and they gain weight during 
these attempts that they never com-
pletely manage to Jose when they 
relapse. Furthermore, with a normal 
BMI, smokers tend to have a greater 
risk of abdominal fat accumulation 
comparecl with nons111okers.6l.77-79 The 
mechanism is not well elucidated but 
because smoking has an anti-
estrogenic effect,80•81 it couic\ be related 
to a hormonal imbalance that couic! 
lead to central obesity. Obesity and 
weight gain are strong risk factors for 
cleveloping type 2 diabetes82•83 and sev-
eral stuclies also show that abdominal 
obesity is associatecl with the clcvelop-
ment of type 2 diabetes.&1,s5 
Limitations of this meta-analysis 
must be consiclered. First, the quality 
of individual studies was not always 
optimal, as shown by the general Jack 
of information on blincling and 
recruiting of consecutive patients for 
al! stuclies. Second, conversion of ORs 
to RRs15 couic! have underestirnated 
the variance of the RRs clerivcd frorn 
ORs. However, a sensitivity analysis 
that exclucled the affected stuclies and 
use of the Miettinen test-based 
approach to calculate variance of the 
lnRR had only an extremely small 
effect on the results. Thircl, there is 
heterogeneity of RRs across studies, 
corresponding in part to heterogeneity 
in study definitions. However, strati-
fied analyses showed pooled RRs con-
sistently greater than 1 across a num-
ber of clinical factors. Fourth, the 
funnel plot analysis showed some 
asymmetiy suggesting the possibility 
of publication bias. The trim and fill 
sensitivity analysis clid not change the 
general result (although the strength 
of the association was slightly attenu-
ated), suggesting that the association 
is not an artifact of unpublishecl nega-
tive studies. Nevertheless, that possi-
bility is not fully excluded by this 
method. 
Consiclering the consistent finding of 
increased cliabetes incidence associ-
atecl with active cigarette smoking 
across a large number of stuclies, we be-
lieve that there is no need for further 
cohort studies to test this hypothesis. 
However, there is a neecl for stuclies that 
include cletailed measurement and ad-
justment for potential confounding fac-
tors such as socioeconomic status, eclu-
cation, and exercise with a goal of 
establishing whether the association 
with smoking is causal. We recom-
mencl that future studies focus on plau-
sible causal mechanisms or mecliating 
factors such as obesity, Jack of physi-
cal activity, dietary habits, and stress 
levels. 
Figure 3. Funnel Plots Without and With Trim and Fill 
[IJ Begg tunnel plot with pseudo 95% Cls 
2 
-2"-r----~ ----~----~-----, 
0 0.2 0.4 0.6 0.8 
SE of Adjusted Log RR of Diabetes for Current Smokers 
[§] Filled tunnel plot with pseudo 95% Cls 
0 
• ldentified studies 
o Estimated missing studies after 
adjustment for publication bias 
0.2 0.4 
0 
0.6 
SE of Adjusted Log RR of Diabetes for Current Smokers, Filled 
0.8 
The pseudo 95% confidence interval (Cl) is computed as part of the analysis that produces the funnel plot, and corresponds to the expected 95% Cl for a given 
standard error (SE). RR indicates relative rislc 
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